TYMS and cancer: The replication of all cells needs thymidine, a pyrimidine which makes up DNA and synthesized in human cells de novo, and the last step of the synthesis is catalyzed by the enzyme TYMS, which is coded by the thyA gene and is the best-known target in anti-cancer therapy as a protein with catalytic and regulatory functions [39,40].